Werewolf Therapeutics Inc (HOWL)

Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.30%13.84	13.27	9.42	15.73	17.54
Research and Development	24.68%6.16	8.18	6.93	11.63	13.14
Operating Income/Loss	153.94%7.16	-13.27	-9.42	-15.73	-17.54
Nonoperating Income/Loss	1,236%-3.49	-0.26	1.04	-0.64	-0.44
	127.12%3.67	-13.53	-8.38	-16.37	-17.98
Attributable To Parent	127.12%3.67	-13.53	-8.38	-16.37	-17.98
Basic Average Shares	0.00%48.60	48.60	-	45.80	44.98
Diluted Average Shares	1.60%48.60	49.39	-	45.80	44.98
Basic Earnings Per Share	128.57%0.08	-0.28	-	-0.36	-0.40
Diluted Earnings Per Share	128.57%0.08	-0.28	-	-0.36	-0.40